These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5215287)

  • 21. Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit.
    Wehner M; Clemens PR; Engel AG; Kilimann MW
    Hum Mol Genet; 1994 Nov; 3(11):1983-7. PubMed ID: 7874115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote.
    Schmidt B; Servidei S; Gabbai AA; Silva AC; de Sousa Bulle de Oliveira A; DiMauro S
    Neurology; 1987 Sep; 37(9):1558-61. PubMed ID: 3476861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).
    Burwinkel B; Maichele AJ; Aagenaes O; Bakker HD; Lerner A; Shin YS; Strachan JA; Kilimann MW
    Hum Mol Genet; 1997 Jul; 6(7):1109-15. PubMed ID: 9215682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myoglobinuria caused by McArdle's disease complicated by anuric acute renal insufficiency].
    Chanard J; Kleinknecht D; Dreyfus JC; Fardeau M; Kaplan M
    Arch Fr Pediatr; 1972 Apr; 29(4):433. PubMed ID: 4506230
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myoglobinuria caused by McArdle's disease complicated by anuric acute renal failure].
    Chanard J; Kleinknecht D; Dreyfus JC; Fardeau M; Kaplan M
    Arch Fr Pediatr; 1972 May; 29(5):505-11. PubMed ID: 4511355
    [No Abstract]   [Full Text] [Related]  

  • 26. Acid maltase deficiency and related myopathies.
    Amato AA
    Neurol Clin; 2000 Feb; 18(1):151-65. PubMed ID: 10658172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [McArdle's disease--description based on three own observations (author's transl)].
    Berger M; Gibbels E; Leven B; Seiler D
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):312-26. PubMed ID: 276513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myophosphorylase deficiency (McArdle's disease) in two interrelated families.
    Cochrane P; Hughes RR; Buxton PH; Yorke RA
    J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):217-24. PubMed ID: 4513544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [McArdle's metabolic myopathy].
    Shutov AA; Bessonov AV; Sidorov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(10):1485-90. PubMed ID: 4530582
    [No Abstract]   [Full Text] [Related]  

  • 30. Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
    Nixon JC; Hobbs WK; Greenblatt J
    Can Med Assoc J; 1966 May; 94(19):977-85. PubMed ID: 4952390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McArdle's disease: a review.
    Lubran MM
    Ann Clin Lab Sci; 1975; 5(2):115-22. PubMed ID: 1092247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy.
    Bruno C; Manfredi G; Andreu AL; Shanske S; Krishna S; Ilse WK; DiMauro S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):648-51. PubMed ID: 9731190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute renal failure in McArdle's disease and myoglobinuric states.
    Paster SB; Adams DF; Hollenberg NK
    Radiology; 1975 Mar; 114(3):567-70. PubMed ID: 1054521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.
    Bogusky RT; Taylor RG; Anderson LJ; Angelos KL; Lieberman JS; Walsh DA
    J Clin Invest; 1986 Jun; 77(6):1881-7. PubMed ID: 3458722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency.
    Carrier H; Maire I; Vial C; Rambaud G; Flocard F; Flechaire A
    Acta Neuropathol; 1990; 81(1):84-8. PubMed ID: 2128163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
    Quinlivan R; Beynon RJ
    Cochrane Database Syst Rev; 2004; (3):CD003458. PubMed ID: 15266486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute renal failure in McArdle's disease. Report of two cases.
    Grünfeld JP; Ganeval D; Chanard J; Fardeau M; Dreyfus JC
    N Engl J Med; 1972 Jun; 286(23):1237-41. PubMed ID: 4502558
    [No Abstract]   [Full Text] [Related]  

  • 38. McArdle's disease. Metabolic studies in a patient and review of the syndrome.
    Fattah SM; Rubulis A; Faloon WW
    Am J Med; 1970 Jun; 48(6):693-9. PubMed ID: 5268114
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
    Bisciglia M; Froissart R; Bedat-Millet AL; Romero NB; Pettazzoni M; Hogrel JY; Petit FM; Stojkovic T
    J Neurol Sci; 2021 May; 424():117391. PubMed ID: 33799212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infantile glycogen storage myopathy in a girl with phosphorylase kinase deficiency.
    Ohtani Y; Matsuda I; Iwamasa T; Tamari H; Origuchi Y; Miike T
    Neurology; 1982 Aug; 32(8):833-8. PubMed ID: 6285226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.